Literature DB >> 29370064

Functional stability of the TEG 6s hemostasis analyzer under stress.

Michael Adam Meledeo1, Grantham C Peltier, Colby S McIntosh, Chet R Voelker, James A Bynum, Andrew P Cap.   

Abstract

BACKGROUND: Viscoelastic measurements of coagulation provide much needed information, including guidance for triage and insight into bleeding disorders. The current clinical standards for these devices are the thromboelastogram (TEG) 5000 and the rotational thromboelastometer (ROTEM) delta, but a new product, the TEG 6s, has recently come to market, designed to simplify the user experience, reduce the required blood volume, and conduct multiple assays simultaneously. This study compares the performance of these three devices and examines the resiliency of the TEG 6s under various stresses.
METHODS: The variances of coagulation metrics obtained by the TEG 6s (prototype and production models), TEG 5000, and ROTEM delta were compared using manufacturers' reagents and citrate-collected blood from healthy donors. Variability between devices was examined, and their performances under various motion and temperature stresses were compared by placing one unit on a linear or orbital shaker, in the cold, or in the heat while a counterpart remained stationary at room temperature.
RESULTS: Although most comparable parameters had low degrees of variance, there were small but significantly increased variances found in some ROTEM delta and TEG 5000 parameters versus comparable TEG 6s parameters. Orbital rotation of the TEG 6s had no effect on means of any parameter but resulted in increased variance of 2 parameters, but linear motion with sudden striking had no observed impact on results. Similarly, 7-day exposure to heat (45°C) or cold (4°C) only resulted in minor deviations within normal ranges of the TEG 6s. DISCUSSION: The TEG 6s provides several improvements over other coagulation analyzers: it is easier to use and robustly resilient against motion and temperature stresses. These features suggest that it may be capable of deployment not only in the clinical laboratory but also to a variety of austere settings. LEVEL OF EVIDENCE: Diagnostic test, level III.

Entities:  

Mesh:

Year:  2018        PMID: 29370064     DOI: 10.1097/TA.0000000000001810

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  5 in total

1.  Assessing TEG6S reliability between devices and across multiple time points: A prospective thromboelastography validation study.

Authors:  Patryck Lloyd-Donald; Leonid Churilov; Brandon Cheong; Rinaldo Bellomo; Peter R McCall; Johan Mårtensson; Neil Glassford; Laurence Weinberg
Journal:  Sci Rep       Date:  2020-04-27       Impact factor: 4.379

2.  A comparison between the TEG 6s and TEG 5000 analyzers to assess coagulation in trauma patients.

Authors:  Matthew D Neal; Ernest E Moore; Mark Walsh; Scott Thomas; Rachael A Callcut; Lucy Z Kornblith; Martin Schreiber; Akpofure Peter Ekeh; Adam J Singer; Lawrence Lottenberg; Michael Foreman; Susan Evans; Robert D Winfield; Michael D Goodman; Carl Freeman; David Milia; Noelle Saillant; Jan Hartmann; Hardean E Achneck
Journal:  J Trauma Acute Care Surg       Date:  2020-02       Impact factor: 3.697

3.  Operability of a Resonance-Based Viscoelastic Haemostatic Analyzer in the High-Vibration Environment of Air Medical Transport.

Authors:  Johannes Zipperle; Bernhard Ziegler; Herbert Schöchl; Wolfgang Voelckel; Christoph J Schlimp; Daniel Oberladstätter
Journal:  J Clin Med       Date:  2022-06-23       Impact factor: 4.964

4.  Modern Management of Bleeding, Clotting, and Coagulopathy in Trauma Patients: What Is the Role of Viscoelastic Assays?

Authors:  Sanjeev Dhara; Ernest E Moore; Michael B Yaffe; Hunter B Moore; Christopher D Barrett
Journal:  Curr Trauma Rep       Date:  2020-01-23

Review 5.  Hemorrhagic Resuscitation Guided by Viscoelastography in Far-Forward Combat and Austere Civilian Environments: Goal-Directed Whole-Blood and Blood-Component Therapy Far from the Trauma Center.

Authors:  James H Lantry; Phillip Mason; Matthew G Logsdon; Connor M Bunch; Ethan E Peck; Ernest E Moore; Hunter B Moore; Matthew D Neal; Scott G Thomas; Rashid Z Khan; Laura Gillespie; Charles Florance; Josh Korzan; Fletcher R Preuss; Dan Mason; Tarek Saleh; Mathew K Marsee; Stefani Vande Lune; Qamarnisa Ayoub; Dietmar Fries; Mark M Walsh
Journal:  J Clin Med       Date:  2022-01-12       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.